FDA Inspection 1335298 — Anieszka Snarska-Drygalska
The FDA completed an inspection of Anieszka Snarska-Drygalska on Jul 24, 2026 in Cracow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cracow (Poland)
Additional Details
Clinical Investigator (CI)